KLK3 and cancer: miR-155 has been shown to be over-expressed in a number of cancers, including PCa, and it has been found that combination of serum miR-155 and PSA measurements are diagnostic of PCa at an early stage, and also reflective of the clinicopathological features of PCa [198].